Fluid challenge and balloon occlusion testing in patients with atrial septal defects.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
12 05 2022
Historique:
received: 15 05 2021
accepted: 10 08 2021
pubmed: 21 8 2021
medline: 18 5 2022
entrez: 20 8 2021
Statut: epublish

Résumé

Careful, stepwise assessment is required in all patients with atrial septal defect (ASD) to exclude pulmonary vascular or left ventricular (LV) disease. Fluid challenge and balloon occlusion may unmask LV disease and post-capillary pulmonary hypertension, but their role in the evaluation of patients with 'operable' ASDs is not well established. We conducted a prospective study in three Italian specialist centres between 2018 and 2020. Patients selected for percutaneous ASD closure underwent assessment at baseline and after fluid challenge, balloon occlusion and both. Fifty patients (46 (38.2, 57.8) years, 72% female) were included. All had a shunt fraction >1.5, pulmonary vascular resistance (PVR) <5 Wood Units (WU) and pulmonary arterial wedge pressure (PAWP) <15 mm Hg. Individuals with a PVR ≥2 WU at baseline (higher PVR group) were older, more symptomatic, with a higher baseline systemic vascular resistance (SVR) than the lower PVR group (all p<0.0001). Individuals with a higher PVR experienced smaller increases in pulmonary blood flow following fluid challenge (0.3 (0.1, 0.5) vs 2.0 (1.5, 2.8) L/min, p<0.0001). Balloon occlusion led to a more marked fall in SVR (p<0.0001) and a larger increase in systemic blood flow (p=0.024) in the higher PVR group. No difference was observed in PAWP following fluid challenge and/or balloon occlusion between groups; four (8%) patients reached a PAWP ≥18 mm Hg following the addition of fluid challenge to balloon occlusion testing. In adults with ASD without overt LV disease, even small rises in PVR may have significant implications on cardiovascular haemodynamics. Fluid challenge may provide additional information to balloon occlusion in this setting.

Identifiants

pubmed: 34413090
pii: heartjnl-2021-319676
doi: 10.1136/heartjnl-2021-319676
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

848-854

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Michele D'Alto (M)

Department of Cardiology, University 'L Vanvitelli' - Monaldi Hospital, Naples, Italy mic.dalto@tin.it.

Andrew Constantine (A)

Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK.
National Heart and Lung Institute, Imperial College London, London, UK.

Massimo Chessa (M)

Pediatric Cardiology Department and GUCH Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Giuseppe Santoro (G)

Heart Hospital "G. Pasquinucci", National Research Council - Tuscany Foundation "G. Monasterio", Massa, Italy.

Gianpiero Gaio (G)

Paediatric Cardiology, University 'L Vanvitelli' - Monaldi Hospital, Naples, Italy.

Mario Giordano (M)

Paediatric Cardiology, University 'L Vanvitelli' - Monaldi Hospital, Naples, Italy.

Emanuele Romeo (E)

Department of Cardiology, University 'L Vanvitelli' - Monaldi Hospital, Naples, Italy.

Paola Argiento (P)

Department of Cardiology, University 'L Vanvitelli' - Monaldi Hospital, Naples, Italy.

Julie Wacker (J)

Pediatric Cardiology Department and GUCH Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Angelo Fabio D'Aiello (AF)

Pediatric Cardiology Department and GUCH Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Berardo Sarubbi (B)

Adult Congenital Heart Disease Unit, Monaldi Hospital, Naples, Italy.

Maria Giovanna Russo (MG)

Paediatric Cardiology, University 'L Vanvitelli' - Monaldi Hospital, Naples, Italy.

Robert Naeije (R)

Department of Pathophysiology, Free University of Brussels Campus de la Plaine, Brussels, Belgium.

Paolo Golino (P)

Department of Cardiology, University 'L Vanvitelli' - Monaldi Hospital, Naples, Italy.

Konstantinos Dimopoulos (K)

Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK.
National Heart and Lung Institute, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH